Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKanabo Grp Plc Regulatory News (KNB)

  • This share is currently suspended. It was suspended at a price of 0.225

Share Price Information for Kanabo Grp Plc (KNB)

Share Price is delayed by 15 minutes
Get Live Data
0.225    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £1.42m
KNB Live PriceLast checked at - London Stock Exchange

Intraday Kanabo Grp Plc Share Chart

AGM Statement

30 Jun 2022 15:29

RNS Number : 8871Q
Kanabo Group PLC
30 June 2022
 

 

Kanabo Group Plc.

("Kanabo" or the "CResult of Annual General Meeting

 

Kanabo Group Plc is pleased to announce that, at the Annual General Meeting ("AGM") held earlier today, all resolutions were duly passed. The numbers of votes for each resolution are presented below:

 

 

 

Chairman of the meeting

FOR

Chairman of the meeting

AGAINST

 

 

 

 

Total Votes Cast

ABSTAIN

Resolution

 

No. of shares

%

No. of shares

%

1

Receive Financial Statements

115,542,133

99.75451

284,339

0.245487

115,826,472

142,706

2

Approve the Directors' Remuneration Report

115,458,280

99.69236

356,288

0.307637

115,814,568

154,610

3

Approve the re-appointment of the auditors and authorize the directors to determine the Auditors' Remuneration

115,553,226

99.75257

286,620

0.247428

115,839,846

129,332

4

Re-elect Andrew Morrison

113,469,744

97.99032

2,327,150

2.009683

115,796,894

172,284

5

Re-elect Avihu Israel Tamir

115,502,424

99.74567

294,510

0.254333

115,796,934

172,244

6

Re-elect David Tsur

115,508,799

99.75078

288,595

0.249224

115,797,394

171,784

7

Elect Daniel Poulter

115,509,839

99.75164

287,595

0.24836

115,797,434

171,744

8

Elect Gil Efron

115,509,839

99.75164

287,595

0.24836

115,797,434

171,744

9

Authorise the directors to allot securities

115,468,984

99.72081

323,278

0.279188

115,792,262

176,916

10*

Authorise the directors to allot Equity Securities

115,469,484

99.72081

323,278

0.279187

115,792,762

176,416

* Special Resolution

 

NOTES:

Votes "For" and "Against" are expressed as a percentage of votes received.

 

 

 

 

For further information, please visit http://www.kanabogroup.com/ or https://www.voxmarkets.co.uk/listings/LON/KNB or contact the following:

 

Kanabo Group Plc

Via Vox Markets

Avihu Tamir, CEO

 

Peterhouse Capital Ltd (Financial Adviser)

Tel: +44 (0)20 7469 0930

Eran Zucker / Lauren Riley

 

Peterhouse Capital Ltd (Corporate Broker)

 

Lucy Williams / Charles Goodfellow

Duncan Vasey / Martin Lampshire

 

 

Vox Markets (Investor Relations)

KanaboGroup@voxmarkets.co.uk

Kat Perez

kperez@voxmarkets.co.uk

 

 

About Kanabo Group Plc

Kanabo Group Plc is creating a new standard in the medical cannabis industry to improve the well-being of millions of people around the world by providing a better alternative to the smoking of medicinal cannabis flowers. Kanabo, which was the first medicinal cannabis company to IPO on London Stock Exchange, has a focus on the distribution of cannabis-derived products for medical patients and non-THC products for CBD consumers.

 

The Company has conducted extensive Research & Development to produce high-quality cannabis extract formulas, innovative medical-grade vaporizers, and various non-smoking consumption solutions. Kanabo sells a range of medical cannabis products and wellness CBD products in the Primary Markets, including its VapePod, which delivers a metered dose with every inhalation.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMEALKEDAKAEFA
Date   Source Headline
11th Dec 202511:30 amRNSDisposal of Subsidiary: The GP Service Limited
28th Nov 20254:02 pmRNSAppointment of Joint Administrators
1st May 20257:30 amRNSSuspension - Kanabo Group plc
30th Apr 20252:47 pmRNSTemporary suspension of listing
4th Apr 20254:20 pmRNSBusiness Update
24th Mar 202511:02 amRNSResignation of Director
4th Mar 20257:00 amRNSRevenue Growth, Trading and Operational Update
6th Jan 20257:00 amRNSDirectorate Change
31st Oct 20249:48 amRNSCorrection Director/PDMR Shareholding
29th Oct 202411:39 amRNSDirector/PDMR Shareholding
30th Sep 20242:50 pmRNSHalf-year Report
28th Aug 20242:31 pmRNSDirector/PDMR Shareholding
27th Jun 20244:49 pmRNSResult of AGM
4th Jun 20247:00 amRNSExpansion:14 New Clinics Partnership with Treat-It
31st May 202410:30 amRNSNotice of AGM
30th Apr 20242:15 pmRNSAnnual Financial Report
28th Mar 20247:00 amRNSExpansion of Treat It to Mental Health Treatments
27th Mar 20245:11 pmRNSHolding(s) in Company
25th Mar 20247:00 amRNSGermany Medical Cannabis Legislation Reform
18th Mar 20249:14 amRNSAgritec Update
15th Jan 20247:00 amRNSPartnership to launch a Walk-In Pain Clinic
14th Nov 20237:00 amRNSContract Extension With Major UK Retailer
2nd Nov 20237:00 amRNSPartnership with BRITISH CANNABISâ„¢
29th Sep 20237:00 amRNSHalf-Year Results
31st Aug 202311:13 amRNSTotal Voting Rights
11th Aug 202311:36 amRNSIssuance of New Ordinary Shares and TVR
26th Jul 20232:00 pmRNSAdmission and Total Voting Rights
24th Jul 20234:10 pmRNSIssuance of New Ordinary Shares and TVR
17th Jul 20237:00 amRNSSuccess for Kanabo Agritec with Contract Award
10th Jul 202311:19 amRNSIssue of New Ordinary Shares and TVR
30th Jun 20232:34 pmRNSResult of AGM
28th Jun 20237:00 amRNSIssue of New Ordinary Shares and TVR
23rd Jun 20237:00 amRNSGrant of Options
13th Jun 20232:39 pmRNSPublication of a Prospectus
8th Jun 20235:19 pmRNSNotice of Annual General Meeting
31st May 202311:30 amRNSTotal Voting Rights
26th May 202310:30 amRNSTotal Voting Rights
23rd May 202311:00 amRNSIssuance of New Ordinary Shares
16th May 20233:00 pmRNSUpdate: Amendments to Acquisition Agreement
16th May 20237:00 amRNSAmendments to Acquisition Agreement
15th May 20237:00 amRNSTotal Voting Rights
12th May 20237:00 amRNSTotal Voting Rights
10th May 20232:52 pmRNSResult of Broker Option
9th May 20237:00 amRNSAppointment of Ian Mattioli as Non-Executive Chair
9th May 20237:00 amRNSFundraise of £2.54 million and Broker Option
4th May 20234:45 pmRNSBoard Change
2nd May 20237:00 amRNSFull Year Results 2022
31st Mar 20232:40 pmRNSDirectorate Change
13th Mar 20237:00 amRNSTreat It Launch: Online Medicinal Cannabis Clinic
7th Mar 202312:15 pmRNSAppointment of Auditor

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.